Real-life data on tapering or discontinuation of canakinumab therapy in patients with familial Mediterranean fever

This study aimed to investigate the disease characteristics of familial Mediterranean fever (FMF) patients undergoing dose optimisation and discontinuation of canakinumab therapy. A total of 61 patients diagnosed with FMF and using canakinumab for the resistant disease were enrolled on this retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Karabulut, Yusuf, Gezer, Halise Hande, Öz, Nuran, Esen, İrfan, Duruöz, Mehmet Tuncay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Observational Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434546/
https://www.ncbi.nlm.nih.gov/pubmed/36048189
http://dx.doi.org/10.1007/s00296-022-05199-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434546/
https://www.ncbi.nlm.nih.gov/pubmed/36048189
http://dx.doi.org/10.1007/s00296-022-05199-w

Ejemplares similares